Report Highlights
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Report Includes
- 58 data tables and 58 additional tables
- An analysis of the current and future global markets and technologies for medical devices
- Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the market size and revenue forecasts for the global medical device market, with market share analysis by device types and subtypes, end-user, and region
- Discussion of the market dynamics, opportunities, and challenges, as well as emerging technologies
- Discussion of key regulations of the industry and coverage of advancements and recent innovations in the medical device industry
- Overview of sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
- Competitive intelligence, including companies’ market shares, recent M&A activity, and venture funding.
- Profiles of the leading companies, including Abbott, BD, Danaher Corp., Medtronic and F. Hoffmann-La Roche Ltd.
Report Scope
This report provides an in-depth analysis of the market for medical device technology, including market estimations and trends through 2029. Major players, competitive intelligence, innovative technologies, market dynamics, and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The report covers drivers, restraints, opportunities, emerging technologies, and a regulatory scenario assessment. The report includes market projections for 2029 and market shares for key players.
The report’s scope extends to only those medical device technologies that generate the most global revenue. Dental device technologies and some imaging devices used in dentistry overlap with other devices that are already covered under the imaging device technologies segments, so these have been excluded.
Based on device type, the market is segmented into drug delivery devices, in vitro diagnostics (IVD), urology and renal, orthopedics and spine, imaging devices, cardiovascular devices, and endoscopy. The imaging devices are categorized into X-ray systems, ultrasound systems, computed tomography, magnetic resonance imaging, clinical/point of care, interventional radiology, nuclear medicine/positron emission tomography, and laser imaging. Based on type of in vitro device, the market is segmented into immunochemistry, clinical chemistry, molecular diagnostics, point-of-care tests, and hematology. Based on type of cardiovascular device, the market is segmented into defibrillators, pacemakers, ventricular-assist devices, loop recorders, and others. Based on type of end user, the market is segmented into hospitals and clinics, home healthcare, ambulatory surgical centers, and diagnostic centers.
The market is segmented by geographical region into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Also included in the geographic breakdown are detailed analyses of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, and Gulf Cooperation Council (GCC) countries. For market estimates, data is provided for 2023 as the base year, with estimates for 2024 and a forecast value for 2029.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||||
| Base year market size | $739.6 Billion | ||||||||||||||||
| Market size forecast | $1.3 Trillion | ||||||||||||||||
| Growth rate | CAGR of 9.8% from 2024 to 2029 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | By Device Type, End-user, and Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and the Rest of the World (RoW) | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, Brazil, Germany, France, U.K., Spain, Italy, Japan, China, India, Australia and New Zealand (ANZ), and GCC countries | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
Partha Sarathi Das– Associate Consultant-Life Science Research
Partha Sarathi has an experience of nearly a decade in multiple domains, including healthcare, life science, biotechnology, pharmaceuticals, and healthcare IT. His expertise is in designing research studies, gathering data, and performing analysis, ultimately providing clients with actionable insights and recommendations based on their unique business needs. Designs proposal and participates in client queries for quick delivery based on their unique business needs. Academically, Parthasarathi holds a master’s degree in Biotechnology and a bachelor’s degree in Industrial Biotechnology.
Consulting Editor’s Credentials
Jason Chen has been an analyst and consultant for the polymer, composite, fibre, textile and energy industries for 19 years. He works as a researcher, writer and/or editor for the American Composites Manufacturers Association (ACMA), China Textile Academy (CTA), China Chemical Fiber Association (CCFA), International Fiber Journal, Filtration News, Platts Emission Daily, Vision Systems Design, Pesticide and Toxic Chemical News and MobileTex. He has a degree in Civil Engineering, Chemicals and Advanced Materials from Shantou University.
Report Highlights
The global market for medical device technologies is valued at $639.1 billion in 2021 and is estimated to grow from $676.0 billion in 2022 to $953.4 billion in 2027 with a compound annual growth rate (CAGR)of 7.1% for the period of 2022-2027.
Report Includes
- 48 data tables and 69 additional tables.
- An up-to-date overview and analysis of the global markets for medical device technologies
- Analyses of the global market trends, with historic sales data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current state and future market potential of medical device technologies, along with a detailed analysis of the competitive environment
- Estimation of the actual market size for medical device technologies, market forecast and corresponding market share analysis by device type and region
- Identification of the key growth driving factors and constraints that will shape the market for medical device technologies as the basis for projecting demand over the next five years (2022-2027)
- Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on drug delivery devices, urology and renal devices, in vitro diagnostic devices, orthopedic and spine devices, imaging devices, cardiovascular devices, and endoscopy devices
- Highlights of the COVID-19 impact on the medical device technologies market, with pandemic implications on the demand and supply of medical devices, pricing analysis, and govt. strategic decisions to boost the marketplace
- Assessment of the company competitive landscape comprising key market participants, their global market share analysis, product portfolio and recent market developments
- Review of patents issued for medical device technologies across each major category, and emerging developments in the global market
- Descriptive company profiles of the leading global players, including Bayer, 3M, Danaher and Smith & Nephew.
Report Highlights
The global market for medical device technologies should grow from $605.7 billion in 2020 to $796.9 billion by 2025 with a compound annual growth rate (CAGR) of 5.6% for the period of 2020-2025.
Report Includes
- 55 data tables and 76 additional tables
- An overview of the global markets and technologies for medical devices
- Analysis of global market trends, with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Discussion on definitions, evolution and types of devices, regulations and legislations, as well as key industry aspects such as market drivers and industry strategies
- An in-depth breakdown of devices by technology type including: imaging devices, in-vitro diagnostic devices, cardiovascular devices, orthopedic and spine, urology and renal devices, endoscopic devices, and drug delivery systems
- Detailed description about COVID-19, including disease progression, symptoms and treatment options and impact analysis of COVID-19 on entire life science industry as well as on medical devices industry
- Evaluation of current market trends, market size, market forecast, and technological advancements within the industry
- Company profiles of major key players in the market, including Boston Scientific Corp., Koninklijke Philips N.V., General Electric Company, Medtronic plc, Siemens Healthcare, and Thermo Fisher Scientific
Report Highlights
The global market for medical devices technologies reached nearly $521.2 billion in 2017 and should reach $674.5 billion by 2022, at a compound annual growth rate (CAGR) of 5.3% for the period of 2017-2022.
Report Includes
- 52 data tables and 85 additional tables
- An overview of the global markets for medical devices technologies
- Analysis of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Discussion of definitions, evolution and types of devices, regulations and legislations, as well as key industry aspects such as market drivers and industry strategies
- An in-depth breakdown of devices by technology type including: imaging devices, in-vitro diagnostic devices, cardiovascular devices, orthopedic and spine, urology and renal devices, endoscopic devices, and drug delivery systems
- Company profiles of major key players in the market, including 3M, Abbot Laboratories, Agilent Technologies, Bayer, GE Healthcare, Johnson & Johnson, Novartis, Siemens Healthcare and Thermo Fisher Scientific
Report Highlights
The global market for medical device technologies reached $458.3 billion in 2015. The market should reach $483.5 billion in 2016 and $634.5 billion by 2021, growing at a compound annual growth rate (CAGR) of 5.6% from 2016 to 2021.
Report Includes
- An overview of the global medical devices markets.
- Analyses of global market trends with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Discussion of definitions, evolution and types of devices, regulations and legislations, as well as key industry aspects such as market drivers and industry strategies.
- Information on the refurbished and replacement market, mergers and acquisitions, market shares for key players, and trends broken down by geography, new technology, and new materials used.
- An in-depth breakdown of devices by technology type including: imaging devices, in-vitro diagnostic devices, cardiovascular devices, orthopedic and spine, urology and renal devices, endoscopic devices, and drug delivery systems.
- Profiles of major players in the industry.
Report Highlights
BCC Research estimates the global market for medical device technologies as $390.3 billion in 2012. This indication has reached $411.8 billion in 2013 and is expected to reach $538.7 billion in 2018, registering a compound annual growth (CAGR) of 5.5% over the next five years.
Report Includes
- An overview of the global medical devices market.
- Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Discussion of definitions, evolution and types of devices, regulations and legislations, as well as key industry aspects such as market drivers and industry strategies.
- Information on the refurbished and replacement market, mergers and acquisitions, market shares for key players, and trends broken down by geography, new technology, and new materials used.
- An in-depth breakdown of devices by technology type including: imaging devices, in-vitro diagnostic devices, cardiovascular devices, orthopedic and spine, urology and renal devices, endoscopic devices, and drug delivery systems.
- Comprehensive company profiles of major players in the industry.
Related Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
Brain-Computer Interface: Global Markets
The global market for brain computer interface (BCI) was valued at $2.1 billion in 2023. The market is expected to grow from $2.3 billion in 2024 to $4.5 billion by 2029, at a compound annual growth rate (CAGR) of 14.2% from 2024 through 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More